Has anyone else been following the NIST guidance on cybersecurity for genomics? โ๐
It validates what many of us working in clinical genomics have been thinking: the old assumptions about lab cybersecurity just don’t hold anymore.โ
The shift is fundamental. Genomic data security isn’t just about locking down a database, or an S3 bucket, it’s about securing an entire workflow. Data is created, moved, transformed, interpreted, shared, and reused. Every step adds exposure. Every handoff matters.โ
Pathology labs have survived with minimal cybersecurity investment because data was local, transient, and operationally siloed on-prem. Systems weren’t internet-facing at scale. Regulatory scrutiny focused on analytical validity, not digital risk.โ
Genomics breaks all these assumptions.โ
NIST identifies what makes genomic data intrinsically unique and high-risk: it’s highly identifiable (potentially re-identified even when “de-identified”), it has long-lived sensitivity (doesn’t expire like a credit card number), it has family linkage (impacts relatives, not just the patient), and it carries high downstream potential harm if integrity is compromised.โ
For clinical settings, this means requirements for integrity, provenance, access control, and audit-ability are heightened. Confidentiality alone isn’t enough.โ
Genomics has turned labs into long-term custodians of highly sensitive, cloud-connected clinical data. And lots of it. Labs need to operate as regulated data services, not just wet labs.โ
They now have lifelong custody of genomic data, not just point-in-time protection. That’s a fundamentally different security model than what most labs were built for.โ
What are you seeing in your labs?โ Reach out to discuss all thing security with us now!
๐ Read more from NIST: https://lnkd.in/e2aehxca
Cybersecurity in Genomics: Protecting Sensitive Genomic Data in Clinical Environments
